Reward deficiency syndrome: Genetic aspects of behavioral disorders

Progress in Brain Research

Volumn 126, Issue , 2000, Pages 325-341

  Comings, David E ^a   Blum, Kenneth ^b,c  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c Department of Integrative Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CANNABINOID; CANNABINOID RECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE TRANSPORTER; OPIATE; OPIATE RECEPTOR;

ADRENERGIC NERVE CELL; ALCOHOLISM; ALLELE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CONFERENCE PAPER; DOPAMINERGIC NERVE CELL; FRONTAL LOBE; GENETIC ANALYSIS; MULTIFACTORIAL INHERITANCE; OBESITY; PATHOLOGICAL GAMBLING; PERSONALITY DISORDER; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REWARD; REWARD DEFICIENCY SYNDROME; SMOKING;

EID: 0034589734     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(00)26022-6     Document Type: Conference Paper

References (153)

1. 2-noradrenergic mechanism to prefrontal cortical cognitive function: Potential significance for attention-deficit hyperactivity disorder. Arch. Gen. Psychiatry, 53:448-455.
2. Arnsten, A.F.T. (1997) Catecholamine regulation of the prefrontal cortex. J. Psychopharmacology, 11: 151-162.
3. Arnsten, A.F.T. and Goldman-Rakic, P.S. (1986) Reversal of stress-induced delayed response deficits in rhesus monkeys by clonidine and naloxone. Soc. Neurosci. Abstr., 12: 1464.
4. Asghari, V., Sanyal, S., Buchwaldt, S., Paterson, A., Jovanovic, V. and Van Tol, H.H.M. (1995) Modulation of interacellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem., 65: 1157-1165.
5. Begleiter, H., Porgesz, B., Bihari, B. and Kissin, B. (1984) Event-related brain potentials in boys at risk for alcoholism. Science, 225: 1493-1495.
6. Benjamin, J., Paterson, C., Greenberg, B., Murphy, D.L. and Hamer, D. (1995) Dopamine D4 receptor gene association with normal personality traits. Psychiat. Genet., 5: S36.
7. Blum, K., Braverman, E.R., Cull, J.G., Eisenberg, A., Sherman, M., Schnautz, N., Fischer, L., Mathews, D. and Comings, D.E. (1997) Association of polymorphisms of dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB) and pathological violence (PV). Biol. Psychiatry, 42: 296S.
8. Blum, K., Braverman, E.R., Wood, R.C., Gill, J., Li, C., Chen, T.J.H., Taub, M., Montgomery, A.R., Sheridan, P.J. and Cull, J.G. (1996a) Increased prevalence of the Taq I A1 allele of the dopamine receptor gene (DRD(2)) in obesity with comorbid substance use disorder: A preliminary report. Pharmacogenetics, 6: 297-305.
9. Blum, K., Cull, J.G., Braverman, E.R. and Comings, D.E. (1996b) Reward deficiency syndrome. Am. Scientist, 84: 132-145.
10. Blum, K., Noble, E.P., Sheridan, P.J., Montgomery, A., Ritchie, T., Jadadeeswaran, P., Nogami, H., Briggs, A.H. and Cohn, J.B. (1990) Allelic association of human dopamine D2 receptor gene in alcoholism. J. Am. Med. Assn., 263: 2055-2059.
11. Blum, K., Sheridan, P.L., Wood, R.C., Braverman, E.R., Chon, J.H., Gull, J.G. and Comings, D.E. (1996) The D2 dopamine receptor gene as determinant of reward deficiency syndrome. J.R. Soc. Med., 89: 396-400.
12. Blum, K., Wood, R.C., Sheridan, P.J., Chen, T. and Comings, D.E. (1995) Dopamine D2 receptor gene variants: Association and linkage studies in impulsive, addictive and compulsive disorders. Pharmacogenetics, 5: 121-141.
13. Bond, M. (1986) Defense style questionnaire. In: G.E. Vaillant (Ed.), Empirical Studies of Ego Mechanisms of Defense. Washington, D.C.: American Psychiatric Press.
14. Braff, D.L., Silverton, L., Saccuzzo, D.P. and Janowsky, D.S. (1981) Impaired speed of visual information processing in marijuana intoxication. Am. J. Psychiatry, 138: 613-617.
15. Broekkamp, C.L.E., Phillips, A.G. and Cools, A.R. (1979) Stimulant effects of enkephalin microinjection into the dopaminergic A10 area. Nature, 278: 560-580.
16. Brunner, H.G., Nelen, M., Breakfield, X.O., Ropers, H.H. and van Oost, B.A. (1993) Abnormal behavior associated with a point mutation in the structural gene for monamine oxidase A. Science, 262: 578-580.
17. Bunzow, J.R., Van Tol, H.H.M., Grandy, D.K., Albert, P., Salon, J., Christie, M., Machida, C.A., Neve, K.A. and Civelli, O. (1988) Cloning and expression of a rat D2 dopamine receptor cDNA. Nature, 336: 783-787.
18. Cadoret, R.J., Troughton, E. and O'Gorman, T.W. (1987) Genetic and environmental factors in alcohol abuse and antisocial personality. J. Stud. Alc., 48: 1-8.
19. Cadoret, R.J., Yates, W.R., Troughton, E., Woodworth, G. and Stewart, M.A. (1995) Adoption study demostrating two genetic pathways to drug abuse. Arch. Gen. Psychiatry, 52: 42-52.
20. Caron, M. (1996) A mouse knockout. Am. J. Psychiatry, 153: 1387.
21. 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology, (Berl.) 102: 156-162.
22. Clarke, P.B.S. (1990) Mesolimbic dopamine activation - The key to nicotine reinforcement. In: The Biology of Nicotine Dependence, Wiley (Ciba Fundation Symposium), Chichester. 152: 153-168.
23. Cloninger, C.R. (1987) A systematic method for clinical description and classification of personality variants: A proposal. Arch. Gen. Psychiatry, 44: 573-588.
24. Cloninger, C.R., Przybeck, T.R. and Svrakic, D.M. (1991) The tridimensional personality questionnaire. U.S. Normative data. Psycol. Rep., 69: 1047-1057.
25. Cloninger, C.R., Sigvardsson, S. and Bohman, M. (1988) Childhood personality predicts alcohol abuse in young adults. Alc. Clin. Exp. Res., 12: 494-505.
26. Cloninger, C.R., Sigvardsson, S., Reich, T. and Bohman, M. (1986) Inheritance of risk to develop alcoholism. Natl. Inst. Drug. Abuse Res. Monogr. Ser., 66: 86-96.
27. Cloninger, C.R., Svrakic, D.M. and Przybeck, T.R. (1993) A psychobiological model of temperament and character. Arch. Gen. Psychiatry, 50: 975-990.
28. Comings, D.E. 1990. Tourette Syndrome and Human Behavior. Duarte, CA: Hope Press.
29. Comings, D.E. (1996) Polygenetic inheritance of psychiatric disorders. In: K. Blum, E.P. Noble, R.S. Sparks and P.J. Sheridan (Eds), Handbook of Psychiatric Genetics. Boca Raton, FL: CRC Press, pp. 235-260.
30. Comings, D.E. (1998a) Polygenic inheritance and micro/minisatellites. Mol. Psvchiatry 3: 21-31.
31. Comings, D.E. (1998b) Why different rules are required for polygenic inheritance: Lessons from studies of the DRD2 gene. Alcohol, 16: 61-70.
32. Comings, D.E. (1999a) Letter to the editor: Tourette syndrome a polygenic disorder. CNS Spectrums, 4: 14-15.
33. Comings, D.E. (1999b) Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density. Mol. Psychiatry, 4: 213-215.
34. Comings, D.E. (1999c) SNPs and polygenic disorders: A less gloomy view. Mol. Psychiatry, 4: 314-316.
35. Comings, D.E. and Comings, B.G. (1993) Comorbid behavioral disorders. In: R. Kurlan (Ed.), Handbook of Tourette's Syndrome and Related Tic and Behavioral Disorders. New York: Marcel-Decker, pp. 111-147.
36. Comings, D.E., Comings, B.G., Muhleman, D., Dietz, G., Shahbahrami, B., Tast, D., Knell, E., Kocsis, P., Baumgarten, R., Kovacs, B.W., Levy, D.L., Smith, M., Kane, J.M., Lieberman, J.A., Klein, D.N., MacMurray, J., Tosk, J., Sverd, J.,Gysin, R. and Flanagan, S. (1991) The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J. Am. Med. Assn., 266: 1793-1800.
37. Comings, D.E., Comings, B.G., Tacket, T. and Li, S. (1990) The clonidine patch and behavioral problems. J. Am. Acad. Child. Adolesc. Psychiatry, 29: 667-668.
38. Comings, D.E., Dietz, G. and Johnson, J.P.M.J.P. (1999) Association of the enkephalinase gene with low amplitude P300 waves. NeuroReport, 10: 2283-2285.
39. Comings, D.E., Flanagan, S.D., Dietz, G., Muhleman, D., Knell, E. and Gysin, R. (1993) The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem. Med. Metabolic Biol., 50: 176-185.
40. Comings, D.E., Gade-Andavolu, R., Gonzalez, N., Blake, H., Wu, S. and MacMurray, J.P. (1999) Additive effect of three noradrenergic genes (ADRA2A, ADRA2C, DBH) on attention deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects. Clin. Genet., 55: 160-172.
41. Comings, D.E., Gade-Andavolu, R., Gonzalez, N., Wu, S., Muhleman, D., Blake, H., Dietz, G., Saucier, G. and MacMurray, J.P. (2000) Comparison of the role of dopamine, serotonin, and noradrenergic genes in ADHD, ODD and conduct disorder. Multivariate regression analysis of 20 genes. Clin. Genet., 57: 178-196.
42. Comings, D.E., Gade, R., Wu, S., Chiu, C., Dietz, G., Muhleman, D., Saucier, G., Ferry, L., Burchete, R., Johnson, P., Verde, R. and MacMurray, J.P. (1997) Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol. Psychiatry, 2: 44-56.
43. Comings, D.E., Gonzalez, N., Wu, S., Gade, R., Muhleman, D., Saucier, G., Johnson, P., Verde, R., Rosenthal, R.J., Lesieur, H.R., Rugle, L.J., Miller, W.R. and MacMurray, J.P. (1999) Studies of the 48 bp repeat of the DRD4 gene in impulsive-addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am. J. Med. Gen. (Neuropsych. Genet.), 88: 358-368.
44. Comings, D.E. and MacMurray, J.M. (1997a) Molecular heterosis: Implications for complex inheritance. Am. J. Hum. Genet., 61: A196.
45. Comings, D.E. and MacMurray, J.M. (1997b) Molecular heterosis: Implications for psychiatric genetics. Am. J. Med. Gen. (Neuropsych. Genet.), 74: 656.
46. Comings, D.E., Muhleman, D., Gade, R., Johnson, P., Verde, R., Saucier, G. and MacMurray, J. (1997) Cannabinoid receptor gene (CNR1): Association with IV drug use. Mol. Psychiatry, 2: 161-168.
47. Comings, D.E., Saucier, G., MacMurray, J.P. (2000) The role of the DRD2 and other dopamine genes in personality traits. In: J. Benjamin, R.P. Ebstein, R.H. Belmaker (Eds), Molecular Genetics and Human Personality, Vol. American Psychiatric Press. (In press)
48. Comings, D.E., Wu, H., Chiu, C., Ring, R.H., Dietz, G. and Muhleman, D. (1996) Polygenic inheritance of Tourette syndrome, stuttering, ADHD, conduct and oppositional defiant disorder: The additive and subtractive effect of the three dopaminergic genes - DRD2, DβH and DAT1. Am. J. Med. Gen. (Neuropsych. Genet.), 67: 264-288.
49. Compton, P.A., Anglin, M.D., Khalsa-Denison, M.E. and Paredes, A.(1996) The D2 dopamine receptor gene, addiction, and personality: Clinical correlates in cocaine abusers. Biol. Psychiatry 39: 302-304. Cook, C.C. and Gurling, H.M. The D2 dopamine receptor gene and alcoholism: A genetic effect in the liability for alcoholism. J.R. Soc. Med., 87: 400-402.
50. Compton, P.A., Anglin, M.D., Khalsa-Denison, M.E. and Paredes, A.(1996) The D2 dopamine receptor gene, addiction, and personality: Clinical correlates in cocaine abusers. Biol. Psychiatry 39: 302-304. Cook, C.C. and Gurling, H.M. The D2 dopamine receptor gene and alcoholism: A genetic effect in the liability for alcoholism. J.R. Soc. Med., 87: 400-402.
51. Cook, E.H., Stein, M.A., Krasowski, M.D., Cox, N.J., Olkon, D.M., Kieffer, J.E. and Leventhal, B.L. (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am. J. Hum. Genet. 56: 993-998.
52. Corrigal, W.A., Coen, K.M. and Adamson, K.L. (1994) Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653: 278-284.
53. Costa, P.T.J. and McCrae, R.R. 1996. The Revised NEO Personality Inventory (NEO-PI-R). J. Cheek and E.M. Donahue, New York: Plenum.
54. Daly, G., Hawi, Z., Fiztgerald, M. and Gill, M. (1999) Mapping susceptability loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry, 4: 192-196.
55. Dawson, E. (1995) Identification of a polymorphic triplet repeat marker for the brain cannabinoid receptor gene: Use in linkage and association studies. Psychiatric Genet., 5: S50.
56. Devane, W.A. and Axelrod, J. (1994) Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc. Natl. Acad. Sci. USA, 91: 6698-6701.
57. Devane, W.A., Hanus, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258:1946-1949.
58. Devor, E.J., Cloninger, C.R., Hoffman, P.L. and Tabakoff, B. (1994) Association of monoamine oxidase (MAO) activity with alcoholism and alcoholic subtypes. Am. J. Med. Genet., 48:209-213.
59. Diamond, B.L. and Borison, R.L. (1978) Enkephalins and nigrostriatal function. Neurology. 28: 1085-1088.
60. DiChiara, G. and Imperato, A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. USA, 85: 5274-5278.
61. DiChiara, G.D. and North, R.A. (1992) Neurobiology of opiate abuse. Trends Pharmacol. Sci., 13: 185-193.
62. Earls, S.F., Reich, W., Jung, K.G. and Cloninger, C.R. (1988) Psychopathology in children of alcoholic and antisocial parents. Alc. Clin. Exp. Res., 12: 481-487
63. Epstein, R.P., Novick, O., Umansky, R., Priel, B., Osher, Y., Blaine, D., Bennett, E.R., Nemanov, L., Katz, M. and Belmaker, R.H. (1996) Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genet., 12: 78-80.
64. Eisen, S.A., Lin, N., Lyons, M.J., True, W.R., Griffith, K., Scherrer, J.F., Goldberg, J. and Tsuang, M.T. (1997) Familial influences on problem gambling: An analysis of 3,359 twin pairs. Am. J. Med. Gen. (Neuropsych. Genet.), 74: 657-658.
65. Gabel, S., Stadler, J., Bjorn, J., Shindledecker, R. and Bowden, C. (1993) Dopamine-beta-hydroxylase in behaviorally disturbed youth. Biol. Psychiatry, 34: 434-442.
66. Gade, R., Muhlemann, D., MacMurray, J. and Comings, D.E. (1998) Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol. Psychiatry, 3: 50-60.
67. Gaoni Y and Mechoulam R (1964) Isolation, stucture and partial synthesis of an active constituent of hashish. J. Am. Chem. Soc., 86: 1646-1647.
68. Gelernter, J., Goldman, D. and Risch, N. (1993) The A1 allele at the D2 dopamine receptor gene and alcoholism. JAMA, 269:1673-1677.
69. Gelernter, J., Kranzler, H., Coccaro, E., Siever, L., New, A. and Mulgrew, C.L. (1997) D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personalitydisorder, and control subjects. Am. J. Med. Genet., 61: 1144-1152.
70. Gill, M., Daly, G., Heron, S., Hawi, Z. and Fitzgerald, M. (1997) Confirmation of association between attention deficit disorder and a dopamine transporter polymorphism. Mol. Psychiatry, 2: 311-313.
71. Giros, B., es, S.R., Wightman, R.M. and Caron, M.G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking dopamine transporter. Nature 379: 606-612.
72. Gorenstein, E.E. (1982) Frontal lobe functions in psychopaths. J. Abnorm. Psychol., 91: 368-379.
73. Gottfries, C.G., Oreland, L., Wiberg, A. and Winblad, B. (1975) Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem., 25: 667-673.
74. Grandy, D.K., Litt, M., Allen, L., Bunzow, J.R., Marchionni, M., Makam, H., Reed, L., Magenis, R.E. and Civelli, O. (1989) The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am. J. Hum. Genet., 45: 778-785.
75. Grice, D.E., Leckman, J.F., Pauls, D.L., Kurlan, R., Kidd, K.K., Pakstis, A.J., Chang, F.M., Buxbaum, J.D., Cohen, D.J. and Gelernter, J. (1996) Linkage disequilibrium of an allele at the dopamine D4 receptor locus with Tourette's syndrome by TDT. Am. J. Hum. Genet., 59: 644-652.
76. Halperin, J.M., Newcorn, J.H., Koda, V.H., Pick, L., McKay, K.E. and Knott, P. (1997) Noradrenergic mechanisms in ADHD children with and without reading disabilities: A replication and extension. J. Am. Acad. Child Adolesc. Psychiatry, 36: 1688-1696.
77. Halperin, J.M., Newcorn, J.H., Schwartz, S.T., McKay, K.E., Bedi, G. and Sharma, V. (1993) Plasma catecholamine metabolites in ADHD boys with and without reading disabilities. J. Clin. Child. Psychol., 22: 219-225.
78. Hare, R.D. (1984) Performance of psychopaths on cognitive tasks related to frontal lobe function. J. Abnorm. Psychol., 93:133-140.
79. Hershkowitz, M., Goldman, R. and Raz, A. (1977) Effect of cannabinoids on neurotransmitter uptake ATPase activity and morphology of mouse brain synaptosomes. Biochem. Pharmacol., 26: 1327-1331.
80. Heyser, C.J., Roberts, A.J., Schulteis, G., Hyytia, P. and Koob, G.F. (1995) Central administration of an opiate antagonist decreases oral administration in rats. Neuroscience Abst., 21: 1698-1690.
81. Hilikas, J.A., Weller, R.A. and Morse, C. (1982) Effects of regular marijuana use on sexual performance. J. Psychoactive Drugs, 14: 59-70.
82. Hill, S.Y., Muka, D., Steinhauer, S. and Locke, J. (1995) P300 amplitude decrements in children from families of alcoholic female probands. Biol. Psychiatry, 38: 622-632.
83. Hollister, L.E. and Gillespie, H.K. (1973) Delta-8- and delta-9-tetrahydrocannabinol comparison in man by oral and intravenous administration. Clin. Pharmacol. Ther., 14: 353-357.
84. Hong, J.S., Yang, H-Y, Fratti, W. and Costa, E. (1977) Determination of methionine-enkephalin in discrete regions of rat brain. Brain Res., 134: 383-386.
85. Howlett, A.C. (1995) Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol., 35: 607-634.
86. Hunt, R.D. (1987) Treatment effects of oral and transdermal clonidine in relation to methylphenidate: An open pilot study in ADD-H. Psychopharmacol. Bull., 23: 111-114.
87. Hunt, R.D., Minderaa, R.B. and Cohen, D.J. (1985) Clonidine benefits children with attention deficit disorder and hyperactivity: Report of a double-blind placebo-crossover therapeutic trial. J. Amer. Acad. Child Psychiatry, 24: 617-629.
88. Johnson, J.P., Dietz, G., Gade-Andavolu, R., Blake, H., Muhleman, D., Saucier, G., MacMurray, J. and Comings, D.E. (1998) Association of endopeptidase (CD10NE) dinucleotide repeat polymorphism with anxiety, depression, and P300 amplitude. International Congress of Psychiatric Genetics, Bonn, Germany. Am. J. Med. Gen. (Neuropsych. Genet.), 81: 524.
89. Johnson, J.P., Muhleman, D., MacMurray, J., Gade, R., Verde, R., Ask, M., Kelley, J. and Comings, D.E. (1997) Association between the cannabinoid receptor gene (CNR1), and the P300 wave of event-related potentials, and drug dependence. Mol. Psychiatry, 2: 169-171.
90. Johnson, K.M., Dewey, W.L. and Harris, L.S. (1976) Some structural requirement for inhibition of high-affinity synaptosomal serotonin uptake by cannabinoids. Mol. Pharmacol., 12:345-352.
91. Jönsson, E., Sedvall, G., Brené, S., Gustavsson, J.P., Geijer, T., Terenius, L., Crocq, M-A., Lannfelt, L., Tylec, T., Sokoloff, P., Schwartz, J.C. and Wiesel, F-A. (1996) Dopamine-related genes and their relationship to monoamine metabolites in CSF. Biol. Psychiatry, 40: 1032-1043.
92. Knell, E. and Comings, D.E. (1993) Tourette syndrome and attention deficit hyperactivity disorder: Evidence for a genetic relationship. J. Clin. Psychiatry, 54: 331-337.
93. Koepp, M.J., Gunn, R.N., Lawrence, A.D., Cunningham, V.J., Dagher, A., Jones, T., Brooks, D.J., Bench, C.J. and Grasby, P.M. (1998) Evidence for striatal dopamine release during a video game. Nature, 393: 266-268.
94. Koob, G.F. (1992) Drug of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci., 13: 177-184.
95. Koob, G.F. and Bloom, F.E. (1988) Cellular and molecular mechanism of drug dependence. Science, 242: 715-723.
96. LaHoste, G.J., Swanson, J.M., Wigal, S.B., Glabe, C., Wigal, T., King, N. and Kennedy, J.L. (1996) Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol. Psychiatry, 1: 121-124.
97. Laurelle, M., Gelernter, J. and Innis, E.B. (1998) D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Mol. Psychiatry, 3: 261-265.
98. LeMoal, M., and Simon, H. (1991) Mesocorticolimbic dopaminergic network: Functional and regulatory roles. Physiol. Rev., 71: 155-234.
99. 9-tetrahydrocannabinol: Comparision with cocaine, morphine, and food reward. Life Sci., 56: 2073-2080.
100. Lichter, J.B., Barr, C.L., Kennedy, J.L., Van Tol, H.H.M., Kidd, K.K. and Livak, K.J. (1993) A hypervariable segment in the human dopamine receptor (DRD4) gene. Hum. Mol. Genet., 2: 767-773.
101. Malhotra, A.K., Virkkunen, M., Rooney, W., Eggert, M., Linnoila, M. and Goldman, D. (1996) The association between the dopamine D4 receptor (DRD4) 16 amino acid repeat polymorphisms and novelty seeking. Mol. Psychiatry 1: 388-391.
102. Mason, S.T. (1980) Noradrenaline and selective attention: A review of the model and the evidence. Life Sci., 27: 617-631.
103. Mattes, J.A. (1980) The role of frontal lobe dysfunction in childhood hyperkinesis. Comp. Psychiatry, 21: 358-369.
104. McCracken, J.T. (1991) A two-part model of stimulant action on attention-deficit hyperactivity disorder in children. J. Neuropsychiatry, 3: 201-209.
105. Merikangas, K.R., Stolar, M., Stevens, D.E., Goulet, J., Preisig, M.A., Fenton, B., Zhang, H., O'Malley, S.S. and Rounsaville, B.J. (1998) Familial transmission of substance use disorders. Arch. Gen. Psychiatry, 55: 973-979.
106. Miller, L. (1987) Neuropsychology of the aggressive psychopath: An integrative review. Aggress. Behav., 13: 119-140.
107. Miller, L.L. (1979) Cannabis and the brain with special reference to the limbic system. In: G.G. Nahas and W.D.M. Paton (Eds), Marihuana Biological Effects. New York: Pergamon Press.
108. Miller, L.L. (1984) Marijuana: Acute affects on human memory. In: S. Agurell, W.L. Dewey and R.E. Willette (Eds) The Cannibinoids: Chemical, Pharmacologic, and Therapeutic Aspects. New York: Academic Press.
109. Moffit, T.E. (1993) Neuropsychology of conduct disorder. Dev. Psychopathol., 1: 135-152.
110. Nicoll, R.A., Alger, B.E. and Jahr, C.E. (1980) Enkephalin blocks inhibitory pathways in the vertebrate CNS. Nature, 287: 22-25.
111. Noble, E.P., Blum, K., Ritchie, T., Montgomery, A. and Sheridan, P.J. (1991) Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch. Gen. Psychiatry 48: 648-654.
112. Noble, E.P., Gottschalk, L.A., Fallon, J.H., Ritchie, T.L. and Wu, J.C. (1997) D2 dopamine receptor polymorphism and brain regional glucose metabolism. Am. J. Med. Genet., 74: 162-166.
113. Noble, E.P., Jeor, S.T., Ritchie, T., Syndulko, K., Jeor, S.C., Fitch, R.J., Brunner, R.L. and Sparkes, R.S. (1994a) D2 dopamine receptor gene and cigarette smoking: A reward gene? Med. Hypoth., 42: 257-260.
114. Noble, E.P., Noble, R.E., Ritchie, T., Grandy, D.K. and Sparkes, R.S. (1994b) D2 Receptor gene and obesity. Int. J. Eating Disorders, 15: 205-217.
115. Noble, E.P., Ozkaragoz, T.E., Ritchie, T.L., Zhang, X., Belin, T.R. and Sparkesm R.S. (1998) D2 and D4 dopamine receptor polymorphisms and personality. Am. J. Med. Genet. (Neuropsychiatric Genet.), 81: 257-267.
116. Novick, O., Ebstein, R., Umansky, R., Priel, B., Osher, Y. and Belmaker, R.H. (1995) D-4 receptor polymorphism associated with personality variation in normals. Psychiatric Genet., 5: S36.
117. Olds, J. and Milner, P. (1954) Positive reinforcement produced by electrical stimulation of septal area and other regions of the rat brain. J. Comp. Physiol. Psychol. 47: 419-427.
118. Pliszka, S.R., Mccracken, J.T. and Maas, J.W. (1996) Catecholamines in attention-deficit hyperactivity disorder: Current perspectives. J. Am. Acad. Child Adolesc. Psychiatry, 35: 264-272.
119. Pohjalainen, T., Rinne, J.O., Någren, K., Lehikoinen, P., Anttila, K., Syvälahati, E.K.G. and Hietala, J. (1998) The A1 allele of the human D2 dopamine receptor gene perdicts low D2 receptor availability in healthy volunteers. Mol. Psychiatry, 3: 256-260.
120. Polich, J., Pollock, V.E. and Bloom, F.E. (1994) Meta-analysis of P300 amplitude from males at risk for alcoholism. Psychol. Bull., 115: 55-73.
121. Pontius, A.A. (1973) Dysfunction patterns analogous to frontal lobe system and caudate nucleus syndrome in some groups of minimal brain dysfunction. J. Am. Med. Women's Assn., 26: 285-292.
122. Pope, H.G. Jr and Yurgelun-Todd, D. (1996) The residual cognitive effects of heavy marijuana use in college students. JAMA 275: 521-527.
123. Posner, M.I. and Peterson, S.E. (1990) The attention system of the human brain. Annu. Rev. Neurosci., 13: 25-42.
124. Prentice, N.M. and Kelly, F.J. (1963) Intelligence and delinquency: A reconsideration. J. Soc. Psychol., 60: 327-337.
125. Prescott, C.A. and Kendler, K.S. (1999) Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am. J. Psychiatry, 156: 34-40.
126. Pugliese, A., Zeller, M., Fewrnandez, A. Jr, Zalcberg, L., Bartlett, R.J., Ricordi, C., Pietropaolo, M., Eisenbarth, G.S., Bennett, S.T. and Patel, D.D. (1997) The insulin gene is transcribed in the human thymus and transcription levels correlate with allelic variation at the INV VNTR-IDDM2 suscepitbility locus for type 1 diabetes. Nature Genet., 15: 293-297.
127. Randrup, A. and Scheel-Kruger, J. (1966) Diethyldithiocarbamate and sterotyped behavior. J. Pharm. Pharmacol., 18: 752.
128. Risch, N. and Merikangas, K. (1996) The future of genetic studies of complex human diseases. Science, 273: 1516-1517.
129. Rogeness, G.A., Maas, J.W., Javors, M.A., Macedo, C.A., Fischer, C. and Harris, W.R. (1989) Attention deficit disorder symptoms and urine catecholamines. Psychiatry Res., 27: 241-251.
130. Routtenberg, A. (1978) The reward system of the brain. Sci. Amer., 239: 154-165.
131. Schmauss, C. and Emrich, H.M. (1985) Dopamine and the action of opiates: A reevaluation of the dopamine hypothesis of schizophrenia. Biol. Psychiatry, 20: 1211-1231.
132. Schooler, C., Zahn, T.P., Murphy, D.L. and Buchsbaum, M.S. (1978) Psychological correlates of monoamine oxidase activity in normals. J. Nerv. Ment. Dis., 166: 177-186.
133. Schultz, W., Dylan, P. and Montague, P.R. (1997) A neural substrate of prediction and reward. Science, 275: 1593-1595.
134. Self, D.W. and Stein, L. (1992) Receptor subtypes in opioid and stimulant reward. Pharmacol. Toxicol., 70: 87-94.
135. Shekim, W.O., Bylund, D.B., Frankel, F., Alexson, J., Jones, S.B., Blue, L.O., Kirby, J. and Corchoran, C. (1989) Platelet MAO activity and personality variations in normals. Psychiatry Res., 27: 81-88.
136. Sherrington, R., Mankoo, B., Attwood, J., Challis, G., Curtis, D., Buetwo, K., Povey, S. and Gurling, H. (1993) Cloning of the human dopamine D5 receptor gene and identification of a highly polymorphic microsatellite for the DRD5 locus that shows tight linkage to the chromosome 4p reference marker RAF1P. Genomics, 18: 423-425.
137. Spitz, M.R., Shi, H., Yang, F., Hudmon, K.S., Jiang, H., Chamberlain, R.M., Amos, C.I., Wan, Y., Cinciripini, P., Hong, W.K. and Wu, X. (1998) Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J. Nat. Canc. Inst., 90: 358-363.
138. Stinus, L., Koob, G.F., Ling, N., Bloom, F.E. and LeMoal, M. (1980) Locomotor activation induced by infusion of endorphins into the ventral tegmental area: Evidence for opiate-dopamine interactions. Proc. Natl. Acad. Sci. USA, 77: 2323-2327.
139. Tanda, G., Pontieri, F.E. and Chiara, G.D. (1997) Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common opioid receptor mechanism. Science, 276: 2048-2049.
140. Tarter, R.E., McBride, H., Bounpane, N. and Schneider, U. (1977) Differentiation of alcoholics: Childhood history of minimal brain dysfunction, family history, and drinking pattern. Arch. Gen. Psychiatry, 34: 761-768.
141. Thierry, A.M., Tassin, J.P., Blanc, G. and Glowinski, J. (1976) Effects of stimulation of the mesocortical dopaminergic system by stress. Nature, 263: 242-244.
142. Tsuang, M.T., Lyons, M.J., Eisen, S.A., Glodberg, J., True, W., Lin, N., Meyer, J.M., Toomey, R., Faraone, S.V. and Eaves, L. (1996) Genetic influences on DMS-III-R drug abuse and dependence: A study of 3,372 twin pairs. Am. J. Med. Gen. (Neuropsych. Genet.), 67: 473-477.
143. Van Tol, H.H.M., Wu, C.M., Guan, H-C., Ohara, K., Bunzow, J.R., Civelli, O., Kennedy, J., Seeman, P., Niznik, H.B. and Javanovic, V. (1992) Multiple dopamine D4 receptor variants in human population. Nature, 358: 149-152.
144. Vandenbergh, D.J., Persico, A.M. and Uhl, G.R. (1992) A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic Taq I RFLPs. Molec. Brain Res., 15: 161-166.
145. Volpicelli, J.R., Alterman, A.I., Hayashida, M. and O'Brien, C.P. (1992) Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry, 49: 876-880.
146. Volpicelli, J.R., Davis, M.A. and Olgin, J.E. (1986) Naltrexone blocks the post-shock increase of ethanol consumption. Life Sci., 38: 841-847.
147. Vonknorring, A.L., Hallmann, J., Vonknorring, L. and Oreland, L. (1991) Platelet monoamine oxidase activity in type-1 and type-2 alcoholism. Alc. Alcohol., 26: 409-416.
148. Wiberg, A., Gottfries, C.G. and Oreland L. (1977) Low platelet monoamine oxidase activity in human alcoholics. Med. Biol., 55:181-186.
149. Winsberg, B. and Comings, D. (1999) Association of the dopamine transporter gene (DAT1) with poor methylphenidate response. J. Am. Acad. Child Adolesc. Psychiatry, 38: 1474-1477.
150. Wise, R.A. and Bozarth, M.A. (1987) A psychomotor stimulant theory of addiction. Psychol. Rev., 94: 469-492.
151. Wise, R.A. and Rompre, P.P. (1989) Brain dopamine and reward. Annu. Rev. Psychol., 40: 191-225.
152. Wood, P.L. (1983) Opioid regulation of CNS dopaminergic pathways: A review of methodology, receptor types, regional variations and species differences. Peptides, 4: 595-601.
153. Yang, H.Y., Hong, J.S. and Costa, E. (1977) Regional distribution of Leu- and Met-enkephalin in rats brain. Neuropharmacology, 16: 303.